News

Antiverse, a biotechnology company developing a computational antibody drug discovery platform, announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition. The collaboration has been successful in...

Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines, announced the opening of its new ATMP development facilities under biosafety level S2 (BSL2 / S2). After one...

Pfizer Inc. and BioNTech SE announced that following a request from the U.S. FDA the companies have initiated a rolling submission seeking to amend the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to include children 6 months...

Britain has already been slow to vaccinate its 5-11 year olds, and they are now not vaccinating them as widely as the United States or Israel. NHS England has confirmed that children in the high-risk group will be the...

Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms...

Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion. The transaction is expected to boost earnings growth of Samsung Biologics on...

Bharat Biotech has been granted permission by India’s drug controller to execute standalone phase 3 clinical trials on the intranasal vaccine for COVID-19. Besides this, the drug regulator has also authorised the Indian biotech giant, which is based in...